Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,640
Total Claims
$978K
Drug Cost
738
Beneficiaries
$1,326
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 109,535 Physician Assistant providers
-82%
Opioid rate vs peers
1.6% vs 9.2% avg
+84%
Cost per patient vs peers
$1,326 vs $719 avg
+87%
Brand preference vs peers
12.4% vs 6.7% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.6%
Opioid Rate
140
Opioid Claims
$2,136
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,071 claims · $815K
Generic: 7,540 claims · $162K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Ibrutinib | 12 | $204K |
| Dulaglutide | 114 | $124K |
| Apixaban | 98 | $94K |
| Fluticasone/Umeclidin/Vilanter | 58 | $47K |
| Semaglutide | 36 | $40K |
| Rivaroxaban | 19 | $27K |
| Mirabegron | 25 | $26K |
| Exenatide Microspheres | 25 | $22K |
| Tirzepatide | 18 | $21K |
| Budesonide/Formoterol Fumarate | 31 | $19K |
| Fluticasone Propionate | 53 | $18K |
| Umeclidinium Brm/Vilanterol Tr | 22 | $15K |
| Ipratropium/Albuterol Sulfate | 14 | $10K |
| Umeclidinium Bromide | 22 | $9,734 |
| Fluticasone Propion/Salmeterol | 18 | $7,786 |
Prescribing Profile
Patient Profile
75
Avg Age
66%
Female
0.98
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About